Even though leptin levels can be considered as a systemic marker for obesity and metabolic syndrome in both genders, it is considered a more reliable diagnostic marker for different types of cancers in females. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.